Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence.

  title={Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence.},
  author={Marsha M. Linehan and Henry Schmidt and Linda A Dimeff and J Chris Craft and Jonathan W. Kanter and Katherine Anne Comtois},
  journal={The American journal on addictions},
  volume={8 4},
A randomized clinical trial was conducted to evaluate whether Dialectical Behavior Therapy (DBT), an effective cognitive-behavioral treatment for suicidal individuals with borderline personality disorder (BPD), would also be effective for drug-dependent women with BPD when compared with treatment-as-usual (TAU) in the community. [] Key Method Subjects were randomly assigned to either DBT or TAU for a year of treatment. Subjects were assessed at 4, 8, and 12 months, and at a 16-month follow-up. Subjects…

Figures and Tables from this paper

A controlled trial of psychodynamic psychotherapy for co-occurring borderline personality disorder and alcohol use disorder.
The results support the feasibility, tolerability, and efficacy of DDP for the co-occurring subgroup and highlight the need for further research.
Use of dialectical behavior therapy skills training for borderline personality disorder in a naturalistic setting
Abstract This nonrandomized, naturalistic study describes a modified outpatient dialectical behavior therapy (DBT) program for borderline personality disorder (BPD) in which some patients receive the
Use of dialectical behavior therapy in inpatient treatment of borderline personality disorder: a systematic review.
Findings suggest that DBT may be effective in reducing symptoms related to borderline personality disorder in inpatient settings, and identifies essential components of an inpatient DBT package and discusses its potential function as an "intensive orientation" to outpatient DBT services.
Dialectical behavior therapy for clients with binge-eating disorder or bulimia nervosa and borderline personality disorder.
From pre- to post-treatment, effect sizes for objective binge eating, total EDE scores and global adjustment were large and for number of non-eating disorder axis I disorders and for suicidal behavior and self-injury were medium.
Dialectical Behavior Therapy for Individuals With Borderline Personality Disorder: A Systematic Review of Outcomes After One Year of Follow-Up.
Dialectical behavior therapy (DBT) has a growing evidence base for treating individuals with a diagnosis of borderline personality disorder (BPD). Less is known about the long-term effects of the
Outcome of dialectical behaviour therapy for concurrent eating and substance use disorders.
The first study to report positive effects of DBT on individuals with concurrent eating and substance use disorders is reported, suggesting that the DBT may be promising for this population.


Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients.
The superiority of DBT over treatment-as-usual, found in previous studies at the completion of 1 year of treatment, was retained during a 1-year follow-up.
Cognitive-behavioral treatment of chronically parasuicidal borderline patients.
Subjects who received dialectical behavior therapy had fewer incidences of parasuicide and less medically severe parasuicides, were more likely to stay in individual therapy, and had fewer inpatient psychiatric days.
Interpersonal outcome of cognitive behavioral treatment for chronically suicidal borderline patients.
The results suggest that dialectical behavior therapy is a promising psychosocial intervention for improving interpersonal functioning among severely dysfunctional patients with borderline personality disorder.
Patients with bulimia nervosa who fail to engage in cognitive behavior therapy.
The group with whom treatment could not begin were found to have a longer history of disorder, to report excessive laxative abuse, to have more severe depressed mood and a greater dissatisfaction with their body weight.
Personality disorder diagnoses in patients with bulimia nervosa: clinical correlates and changes with treatment.
The data suggest that the assessment of Axis II disorders in patients with bulimia nervosa is problematic and raise the possibility that personality features in this group may be influenced by the course of their Axis I disorder.
Axis II comorbidity in substance abusers.
Because of the marked differences between the substance abusers with and without personality disorders, a uniform approach to substance abuse treatment may be inadequate.
Is there any drug treatment of choice for the borderline patient?
  • P. Soloff
  • Psychology
    Acta psychiatrica Scandinavica. Supplementum
  • 1994
The efficacy of neuroleptics, antidepressants, TCA, MAOI and SSRI, lithium carbonate, carbamazepine and benzodiazepines against these 4 symptom domains is reviewed.
Clinicians' experiences in combining medication and psychotherapy in the treatment of borderline patients.
Therapists were most likely to prescribe medications when they felt pessimistic about patients' capacity to benefit from psychotherapy and were rarely willing to prescribing medications for patients who had a history of substance abuse or suicide attempts.
Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine.
Patterns of pharmacological response may provide clues to biological mechanisms underlying dysphoria and behavioral dyscontrol in patients with borderline personality disorder.